Allevi

PHILADELPHIA, PA · Founded 2014 · Biotech · Acquired

3D bioprinting platform that deposits cellular material layer-by-layer to construct functional tissue constructs

Claim this profile

Follows are private to you and power your alerts

Updated · allevi3d.com

Sector
Biotech
Headquarters
PHILADELPHIA, PA
Founded
2014
Latest Form D
$1M, Oct 2019
Total capital
$2M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$1.9M
3 Form D · last Oct 2019
84 months since last filing
Federal contracts
$49K
4 awards · Defense, Health and Human S
Rank in Biotech#355 of 4373
Granted patents
2
5 pending · first 2021
Rank in peer group#4 of 32

Capital timeline

20152016201720182019FEDERAL ↑EQUITY ↓Cumulative $2M$25K$11K$12K1st Form D$877K2nd Form D$30K3rd Form D$1M
20152016201720182019FEDERAL ↑EQUITY ↓Cumulative $2M$25K$11K$12K1st Form D$877K3rd Form D$1M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$1M
  • Federal contractDefense · 3D Bioprinter U433D80$12K
  • Private capital raisedForm D · SEC · 2nd filing$30K
  • Federal contractDefense · 3D Bioprinter$11K
  • Federal contractDefense · Biobots 3D Printer$25K
  • Private capital raisedForm D · SEC · 1st filing$877K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 32 peers

Line = median

Biotech · Device

  • Granted patents#4 · top 13%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Ricardo SolorzanoResearcherExecutive Officer, DirectorLinked by 2 patents
  • Angelo MasciantonioDirectorNamed in SEC Form D filings
  • David JosephDirectorNamed in SEC Form D filings
  • Evangeline GonzalezDirectorNamed in SEC Form D filings
  • Frank McCaneyDirectorNamed in SEC Form D filings
  • Madeline WinterExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 7
Show all 7 patent records

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .